Document Detail


Heme oxygenase-1 and iron in liver inflammation: a complex alliance.
MedLine Citation:
PMID:  20704547     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Heme oxygenase (HO)-1 is the inducible isoform of the first and rate-limiting enzyme of heme degradation. HO-1 has potent antioxidant and also anti-inflammatory functions, the underlying mechanisms of which are not well understood. Together with antioxidant carbon monoxide and biliverdin, HO produces reactive iron, which unambiguously connect this enzyme with the iron metabolism and its potential toxicity. A link between HO-1 and iron homeostasis has been demonstrated in HO-1 knockout mice, which develop major hemosiderosis in solid organs such as liver and kidney. Moreover, genetic HO-1 deficiency causes a chronic inflammatory condition in these animals. As the liver plays a crucial role for the body's iron homeostasis (eg. via secretion of the iron regulatory hormone hepcidin) and also for systemic inflammation, hepatic HO-1 may be important for the regulation of both systems. In particular, cell-specific functions of HO-1 in liver tissue macrophages (Kupffer cells) might be of major significance, because these cells play a key role in iron recycling during erythrophagocytosis and also in the control of hepatic and systemic inflammatory responses. This review discusses the current knowledge on interactions of HO-1 with iron metabolism in the context of systemic as well as hepatic inflammatory disorders. Recent advances in the understanding of the functional role of HO-1 in inflammatory liver diseases, namely viral hepatitis, alcoholic liver disease and non-alcoholic steatohepatitis are summarized. Finally, it is highlighted how targeted modulation of HO-1 may provide specific protection in these inflammatory disorders.
Authors:
Stephan Immenschuh; Eveline Baumgart-Vogt; Sebastian Mueller
Related Documents :
22432127 - Stress and inflammatory disease: widening roles for serotonin and substance p.
16911567 - Nomadic or sessile: can kupffer cells function as portals for malaria sporozoites to th...
12859717 - Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection.
11750117 - Early hepatic cytokine mrna expression in experimental rat fasciolosis.
12946237 - Th1/th2 balance: the hypothesis, its limitations, and implications for health and disease.
18271077 - Toll-like receptor signaling is impaired in dendritic cells from patients with x-linked...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current drug targets     Volume:  11     ISSN:  1873-5592     ISO Abbreviation:  Curr Drug Targets     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-10-29     Completed Date:  2011-02-28     Revised Date:  2011-09-12    
Medline Journal Info:
Nlm Unique ID:  100960531     Medline TA:  Curr Drug Targets     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1541-50     Citation Subset:  IM    
Affiliation:
Institute for Transfusion Medicine, Hannover Medical School, 30625 Hannover, Germany. Immenschuh.Stephan@mh-hannover.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Inflammatory Agents, Non-Steroidal / pharmacology,  therapeutic use
Cytophagocytosis
Enzyme Induction / drug effects
Erythrocytes / metabolism
Gene Therapy
Heme Oxygenase-1 / biosynthesis,  genetics,  metabolism*
Hepatitis / drug therapy,  metabolism*,  physiopathology*,  therapy
Homeostasis
Humans
Iron / metabolism*
Kupffer Cells / physiology
Liver / drug effects,  physiopathology
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 7439-89-6/Iron; EC 1.14.99.3/Heme Oxygenase-1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Heme oxygenase-1 in tumor biology and therapy.
Next Document:  Heme oxygenase-1 in lung disease.